JP2024525150A5 - - Google Patents

Info

Publication number
JP2024525150A5
JP2024525150A5 JP2023577130A JP2023577130A JP2024525150A5 JP 2024525150 A5 JP2024525150 A5 JP 2024525150A5 JP 2023577130 A JP2023577130 A JP 2023577130A JP 2023577130 A JP2023577130 A JP 2023577130A JP 2024525150 A5 JP2024525150 A5 JP 2024525150A5
Authority
JP
Japan
Prior art keywords
groups
group
unsubstituted
substituted
alkyloxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023577130A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525150A (ja
JP7886355B2 (ja
Filing date
Publication date
Priority claimed from EP21315095.6A external-priority patent/EP4105218A1/en
Application filed filed Critical
Priority claimed from PCT/EP2022/066231 external-priority patent/WO2022263472A1/en
Publication of JP2024525150A publication Critical patent/JP2024525150A/ja
Publication of JP2024525150A5 publication Critical patent/JP2024525150A5/ja
Application granted granted Critical
Publication of JP7886355B2 publication Critical patent/JP7886355B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023577130A 2021-06-15 2022-06-14 置換ピロロ[2,3-d]ピリミジン類、それらの製造及びそれらの治療適用 Active JP7886355B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21315095.6A EP4105218A1 (en) 2021-06-15 2021-06-15 Substituted pyrrolo[2,3-d] pyrimidines, their preparation and their therapeutic application
EP21315095.6 2021-06-15
EP22315117.6 2022-06-02
EP22315117 2022-06-02
PCT/EP2022/066231 WO2022263472A1 (en) 2021-06-15 2022-06-14 Substituted pyrrolo[2,3-d]pyrimidines, their preparation and their therapeutic application

Publications (3)

Publication Number Publication Date
JP2024525150A JP2024525150A (ja) 2024-07-10
JP2024525150A5 true JP2024525150A5 (cg-RX-API-DMAC7.html) 2025-06-12
JP7886355B2 JP7886355B2 (ja) 2026-07-07

Family

ID=82214141

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023577130A Active JP7886355B2 (ja) 2021-06-15 2022-06-14 置換ピロロ[2,3-d]ピリミジン類、それらの製造及びそれらの治療適用

Country Status (11)

Country Link
US (1) US20240383901A1 (cg-RX-API-DMAC7.html)
EP (1) EP4355748B1 (cg-RX-API-DMAC7.html)
JP (1) JP7886355B2 (cg-RX-API-DMAC7.html)
KR (1) KR20240021910A (cg-RX-API-DMAC7.html)
AU (1) AU2022294022A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023025042A2 (cg-RX-API-DMAC7.html)
CA (1) CA3223786A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024000083A2 (cg-RX-API-DMAC7.html)
IL (1) IL309195A (cg-RX-API-DMAC7.html)
MX (1) MX2023015016A (cg-RX-API-DMAC7.html)
WO (1) WO2022263472A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL330303A (en) * 2023-12-27 2026-08-01 Sanofi Modified pyrrolo[2,3-d]pyrimidins, their preparation and therapeutic applications
KR20250163526A (ko) 2024-05-14 2025-11-21 김성우 음전하 증폭장치가 장착된 어싱용 발판

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI398252B (zh) * 2006-05-26 2013-06-11 諾華公司 吡咯并嘧啶化合物及其用途
FR2988722B1 (fr) 2012-04-03 2014-05-09 Sanofi Sa Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
CN106146515B (zh) 2015-04-17 2020-09-04 常州隆赛医药科技有限公司 新型激酶抑制剂的制备及应用
US11214565B2 (en) 2015-11-20 2022-01-04 Denali Therapeutics Inc. Compound, compositions, and methods
CN108934162A (zh) 2015-12-16 2018-12-04 南方研究所 吡咯并嘧啶化合物、作为激酶lrrk2抑制剂的用途及其制备方法
EP3587422A4 (en) 2017-02-22 2020-05-06 Daegu-Gyeongbuk Medical Innovation Foundation PYRROLOPYRIMIDINE DERIVATIVE COMPOUND, PRODUCTION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION WITH THIS COMPOUND AS AN ACTIVE SUBSTANCE FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASE
EP3873471B1 (en) 2018-10-31 2025-12-31 Merck Sharp & Dohme LLC N-HETEROARYL INDAZOLE DERIVATIVES AS LRRK2 INHIBITORS: PHARMACEUTICAL COMPOSITIONS AND THEIR USES
EP3915985A4 (en) 2019-01-18 2022-09-28 Voronoi Co., Ltd. PYRROLOPYRIDE DERIVATIVE AND USE THEREOF FOR THE PREVENTION AND TREATMENT OF PROTEIN KINASE RELATED DISEASES

Similar Documents

Publication Publication Date Title
CN107089985B (zh) 作为詹纳斯相关激酶(jak)抑制剂的吡咯并[2,3-d]嘧啶衍生物
CN105669676B (zh) 制备jak抑制剂及相关中间化合物的方法
US12624028B2 (en) 1H-pyrazolo[4,3-G]isoquinoline and 1H-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)
MD4800C1 (ro) Compuşi de aminopirimidinil ca inhibitori de JAK
JP2025521545A (ja) 脊髄小脳失調症3型を処置するための化合物
EP3180344A1 (en) Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase
JP2013503191A (ja) ヤヌスキナーゼインヒビターとしての複素環式化合物
US11273168B2 (en) Methods of treating anxiety by administering a substituted quinolone
JP7112755B2 (ja) Jak酵素阻害剤及びその製造方法と用途
US20190211021A1 (en) Preparation Method For Chiral Pyrrolopyrimidine Compound
RS65308B1 (sr) Biciklična ketonska jedinjenja i postupci za njihovu upotrebu
JP2020536915A (ja) Rip1キナーゼ阻害剤として使用するための二環式化合物
CN107667097B (zh) 3-乙基双环[3.2.0]庚-3-烯-6-酮的对映体的分离
EP3704097A1 (en) Bicyclic sulfones and sulfoxides and methods of use thereof
JP2021100953A (ja) ピリミジニルシクロペンタン化合物の調製方法
JP2017515845A5 (cg-RX-API-DMAC7.html)
WO2021084498A1 (en) Fluorinated quinoline, quinoxaline and benzo[b][1,4]oxazine derivatives as dihydroorotate dehydrogenase (dhodh) inhibitors for the treatment of cancer, autoimmune and inflammatory diseases
JP7688449B2 (ja) ピリジン縮合環系化合物とその製造方法、中間体、組成物及び使用
JP2025506729A (ja) チエノピロロトリアジン化合物、それらの調製及びそれらの治療的使用
WO2023001247A1 (zh) 哒嗪酮类化合物
CN116425770A (zh) 作为Cdc7抑制剂的四并环类化合物
US20240034739A1 (en) Processes for making bicyclic ketone compounds
TWI878888B (zh) Ripk1抑制劑及使用方法
WO2013137479A1 (en) Decahydroquinoxaline derivatives and analogs thereof
RU2024100573A (ru) Замещенные пирроло[2,3-d]пиримидины, их получение и их терапевтическое применение